Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ginkgo Bioworks Holdings, Inc.DNA · Entity 5530 | 10% owner | July 28, 2026 | July 30, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ginkgo Bioworks Holdings, Inc.
Report date July 28, 2026 · Filed July 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 35,736 |
Reported balance
After 2026-07-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-28 · Grant · Acquired 35,736 · Balance 35,736 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2: The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% on October 16, 2026 and 25% on January 21, 2027. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 117,135 |
Reported balance
After 2026-07-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-28 · Grant · Acquired 117,135 · Balance 117,135 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3: The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters, with the first vesting to occur on October 16, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | IndirectBy Spouse | 39,038 |
Reported balance
After 2026-07-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-07-28 · Grant · Acquired 39,038 · Balance 39,038 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2: The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% on October 16, 2026 and 25% on January 21, 2027. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | IndirectBy Spouse | 127,423 |
Reported balance
After 2026-07-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-07-28 · Grant · Acquired 127,423 · Balance 127,423 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3: The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters, with the first vesting to occur on October 16, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F2: The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% on October 16, 2026 and 25% on January 21, 2027.
F3: The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters, with the first vesting to occur on October 16, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2023 Filed Mar 17, 2023 20:58 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 37,650 | $1.32 | $49,547.40 |
DisclosureSEC source: 0001127602-23-010719 · form4.xml · nonDerivative · entry 1 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 13,880,554 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person or the Reporting Person's spouse and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.28 to $1.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| March 14, 2023 Filed Mar 16, 2023 21:27 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 37,650 | $1.33 | $50,074.50 |
DisclosureSEC source: 0001127602-23-010464 · form4.xml · nonDerivative · entry 2 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 13,918,204 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person or the Reporting Person's spouse and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.295 to $1.395, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| March 14, 2023 Filed Mar 16, 2023 21:27 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 75,300 | $1.33 | $100,149.00 |
DisclosureSEC source: 0001127602-23-010464 · form4.xml · nonDerivative · entry 1 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,918,194 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person or the Reporting Person's spouse and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.295 to $1.395, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:28 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 37,650 | $1.39 | $52,484.10 |
DisclosureSEC source: 0001127602-23-008820 · form4.xml · nonDerivative · entry 1 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 13,955,854 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person or the Reporting Person's spouse and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.33 to $1.475, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| February 23, 2023 Filed Feb 24, 2023 22:11 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 37,650 | $1.61 | $60,428.25 |
DisclosureSEC source: 0001127602-23-007097 · form4.xml · nonDerivative · entry 2 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,993,494 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person or the Reporting Person's spouse and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.545 to $1.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 22:11 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 37,650 | $1.65 | $61,971.90 |
DisclosureSEC source: 0001127602-23-007097 · form4.xml · nonDerivative · entry 1 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 13,993,504 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person or the Reporting Person's spouse and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.59 to $1.685, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 22:09 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 37,650 | $1.77 | $66,791.10 |
DisclosureSEC source: 0001127602-23-005896 · form4.xml · nonDerivative · entry 2 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,031,144 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person or the Reporting Person's spouse and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.72 to $1.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 22:09 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 37,650 | $1.79 | $67,393.50 |
DisclosureSEC source: 0001127602-23-005896 · form4.xml · nonDerivative · entry 1 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 14,031,154 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person or the Reporting Person's spouse and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.705 to $1.845, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| February 09, 2023 Filed Feb 10, 2023 21:43 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 37,650 | $1.81 | $68,221.80 |
DisclosureSEC source: 0001127602-23-004490 · form4.xml · nonDerivative · entry 1 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,068,794 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person or the Reporting Person's spouse and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.74 to $1.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| February 08, 2023 Filed Feb 9, 2023 21:34 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 128,864 | $1.88 | $242,650.91 |
DisclosureSEC source: 0001127602-23-004238 · form4.xml · nonDerivative · entry 5 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 14,068,804 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| February 08, 2023 Filed Feb 9, 2023 21:34 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 37,650 | $1.87 | $70,480.80 |
DisclosureSEC source: 0001127602-23-004238 · form4.xml · nonDerivative · entry 4 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 14,197,668 F2 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person or the Reporting Person's spouse and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.805 to $1.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| February 08, 2023 Filed Feb 9, 2023 21:34 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 128,864 | $1.88 | $242,650.91 |
DisclosureSEC source: 0001127602-23-004238 · form4.xml · nonDerivative · entry 3 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,106,444 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 21:34 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 151,769 | $1.96 | $297,619.01 |
DisclosureSEC source: 0001127602-23-004238 · form4.xml · nonDerivative · entry 2 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 14,235,318 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 21:34 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 151,769 | $1.96 | $297,619.01 |
DisclosureSEC source: 0001127602-23-004238 · form4.xml · nonDerivative · entry 1 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,235,308 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 21:41 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 157,790 | $1.98 | $312,897.57 |
DisclosureSEC source: 0001127602-23-003806 · form4.xml · nonDerivative · entry 4 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 14,387,087 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 21:41 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 157,789 | $1.98 | $312,895.59 |
DisclosureSEC source: 0001127602-23-003806 · form4.xml · nonDerivative · entry 3 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,387,077 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 21:41 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 156,383 | $2.13 | $332,626.64 |
DisclosureSEC source: 0001127602-23-003806 · form4.xml · nonDerivative · entry 2 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 14,544,877 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 21:41 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 156,382 | $2.13 | $332,624.51 |
DisclosureSEC source: 0001127602-23-003806 · form4.xml · nonDerivative · entry 1 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,544,866 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 22:11 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 37,650 | $2.17 | $81,617.67 |
DisclosureSEC source: 0001127602-23-003386 · form4.xml · nonDerivative · entry 1 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,701,248 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person or the Reporting Person's spouse and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.07 to $2.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 22:24 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 154,910 | $1.91 | $296,187.92 |
DisclosureSEC source: 0001127602-23-003181 · form4.xml · nonDerivative · entry 5 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 14,701,260 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 22:24 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 37,650 | $1.93 | $72,641.91 |
DisclosureSEC source: 0001127602-23-003181 · form4.xml · nonDerivative · entry 4 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 14,856,170 F2 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person or the Reporting Person's spouse and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.87 to $2.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 22:24 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 154,910 | $1.91 | $296,187.92 |
DisclosureSEC source: 0001127602-23-003181 · form4.xml · nonDerivative · entry 3 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,738,898 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 22:24 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 149,554 | $1.85 | $276,375.79 |
DisclosureSEC source: 0001127602-23-003181 · form4.xml · nonDerivative · entry 2 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 14,893,820 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 22:24 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 149,554 | $1.85 | $276,375.79 |
DisclosureSEC source: 0001127602-23-003181 · form4.xml · nonDerivative · entry 1 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,893,808 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| January 30, 2023 Filed Jan 31, 2023 22:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 156,012 | $1.89 | $294,706.67 |
DisclosureSEC source: 0001127602-23-002756 · form4.xml · nonDerivative · entry 4 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 15,043,374 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| January 30, 2023 Filed Jan 31, 2023 22:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 156,012 | $1.89 | $294,706.67 |
DisclosureSEC source: 0001127602-23-002756 · form4.xml · nonDerivative · entry 3 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,043,362 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| January 27, 2023 Filed Jan 31, 2023 22:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 145,906 | $1.82 | $265,840.73 |
DisclosureSEC source: 0001127602-23-002756 · form4.xml · nonDerivative · entry 2 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 15,199,386 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| January 27, 2023 Filed Jan 31, 2023 22:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 145,907 | $1.82 | $265,842.55 |
DisclosureSEC source: 0001127602-23-002756 · form4.xml · nonDerivative · entry 1 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,199,374 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| January 26, 2023 Filed Jan 27, 2023 22:17 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 151,171 | $1.77 | $267,270.33 |
DisclosureSEC source: 0001127602-23-002473 · form4.xml · nonDerivative · entry 3 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 15,345,292 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| January 26, 2023 Filed Jan 27, 2023 22:17 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 37,650 | $1.76 | $66,324.24 |
DisclosureSEC source: 0001127602-23-002473 · form4.xml · nonDerivative · entry 2 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,345,281 F2 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person or the Reporting Person's spouse and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.72 to $1.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| January 26, 2023 Filed Jan 27, 2023 22:17 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 151,171 | $1.77 | $267,270.33 |
DisclosureSEC source: 0001127602-23-002473 · form4.xml · nonDerivative · entry 1 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,382,931 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| January 25, 2023 Filed Jan 26, 2023 22:06 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 158,748 | $1.73 | $274,951.54 |
DisclosureSEC source: 0001127602-23-002316 · form4.xml · nonDerivative · entry 5 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 15,496,463 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| January 25, 2023 Filed Jan 26, 2023 22:06 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 37,650 | $1.73 | $65,157.09 |
DisclosureSEC source: 0001127602-23-002316 · form4.xml · nonDerivative · entry 4 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 15,655,211 F2 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person or the Reporting Person's spouse and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.69 to $1.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| January 25, 2023 Filed Jan 26, 2023 22:06 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 158,748 | $1.73 | $274,951.54 |
DisclosureSEC source: 0001127602-23-002316 · form4.xml · nonDerivative · entry 3 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,534,102 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| January 24, 2023 Filed Jan 26, 2023 22:06 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 153,994 | $1.82 | $279,499.11 |
DisclosureSEC source: 0001127602-23-002316 · form4.xml · nonDerivative · entry 2 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 15,692,861 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| January 24, 2023 Filed Jan 26, 2023 22:06 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 153,994 | $1.82 | $279,499.11 |
DisclosureSEC source: 0001127602-23-002316 · form4.xml · nonDerivative · entry 1 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,692,850 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| January 23, 2023 Filed Jan 24, 2023 22:29 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 143,807 | $1.75 | $252,093.67 |
DisclosureSEC source: 0001127602-23-002138 · form4.xml · nonDerivative · entry 4 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 15,846,855 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| January 23, 2023 Filed Jan 24, 2023 22:29 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 143,808 | $1.75 | $252,095.42 |
DisclosureSEC source: 0001127602-23-002138 · form4.xml · nonDerivative · entry 3 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,846,844 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 22:29 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 152,205 | $1.67 | $253,573.53 |
DisclosureSEC source: 0001127602-23-002138 · form4.xml · nonDerivative · entry 2 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 15,990,662 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 22:29 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 152,205 | $1.67 | $253,573.53 |
DisclosureSEC source: 0001127602-23-002138 · form4.xml · nonDerivative · entry 1 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,990,652 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| January 19, 2023 Filed Jan 20, 2023 22:21 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 162,193 | $1.71 | $277,998.80 |
DisclosureSEC source: 0001127602-23-001969 · form4.xml · nonDerivative · entry 3 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 16,142,867 F3 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| January 19, 2023 Filed Jan 20, 2023 22:21 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 162,193 | $1.71 | $277,998.80 |
DisclosureSEC source: 0001127602-23-001969 · form4.xml · nonDerivative · entry 2 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,142,857 F3 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| January 19, 2023 Filed Jan 20, 2023 22:21 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 37,650 | $1.69 | $63,492.96 |
DisclosureSEC source: 0001127602-23-001969 · form4.xml · nonDerivative · entry 1 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,305,050 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person or the Reporting Person's spouse and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.64 to $1.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| January 18, 2023 Filed Jan 19, 2023 23:09 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 154,795 | $1.95 | $302,159.84 |
DisclosureSEC source: 0001127602-23-001852 · form4.xml · nonDerivative · entry 5 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 16,305,060 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| January 18, 2023 Filed Jan 19, 2023 23:09 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 37,650 | $1.92 | $72,363.30 |
DisclosureSEC source: 0001127602-23-001852 · form4.xml · nonDerivative · entry 4 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 16,459,855 F2 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person or the Reporting Person's spouse and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.81 to $2.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| January 18, 2023 Filed Jan 19, 2023 23:09 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 154,796 | $1.95 | $302,161.79 |
DisclosureSEC source: 0001127602-23-001852 · form4.xml · nonDerivative · entry 3 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,342,700 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 23:09 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 151,530 | $1.86 | $282,451.92 |
DisclosureSEC source: 0001127602-23-001852 · form4.xml · nonDerivative · entry 2 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 16,497,505 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 23:09 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 151,531 | $1.86 | $282,453.78 |
DisclosureSEC source: 0001127602-23-001852 · form4.xml · nonDerivative · entry 1 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,497,496 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 23:02 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 157,626 | $1.77 | $279,470.90 |
DisclosureSEC source: 0001127602-23-001486 · form4.xml · nonDerivative · entry 2 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 16,649,035 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 23:02 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 157,627 | $1.77 | $279,472.67 |
DisclosureSEC source: 0001127602-23-001486 · form4.xml · nonDerivative · entry 1 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,649,027 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.